He serves on the editorial boards of Toxicology & Applied Pharmacology, the Journal of Toxicology and Environmental Health and Toxicology. Dr. Willhite has published primarily in developmental toxicology and quantitative structure-activity relationships. Dr. Willhite has been a member of the National Academy’s Committee on Toxicology, the U.S. EPA’s National Advisory Committee, the NTP’s SACATM, ILSI’s Structure-Activity Database Project, the National Research Council’s Submarine Air Quality and Acute Exposure Guidelines Subcommittees, the NSF Health Advisory Board, the ACGIH Committee on Threshold Limit Values, the IARC Cancer Chemoprevention Panel, and the Cal/OSHA’s Lead in Construction PEL Committee.
Read MoreSyed A. Sattar is Founding Director of the Centre for Research on Environmental Microbiology (CREM), and also Professor Emeritus of Microbiology at the University of Ottawa. He regularly provides scientific and technical input to regulatory agencies, international organizations, as well as the private sector. He is a registered member of the Canadian College of Microbiologists and a Fellow of the American Academy of Microbiology, and was also recently appointed Senior Scientific Advisor to Health Science North (Sudbury, ON, Canada).
Read MoreProfessor Len Ritter is currently Professor Emeritus of Toxicology in the School of Environmental Sciences at the University of Guelph. Len has served on various expert panels and boards including the International Centre on Pesticide Safety, the U.S. National Academy of Sciences, the National Cancer Institute of Canada and the Canadian Cancer Society, the US National Cancer Institute, and the World Health Organization Joint Expert Committee on Food Additives. Len advises government departments and agencies, and various industries, in Canada and abroad on issues related to pesticides, risks from exposure to toxic chemicals, and human health risk assessment.
Read MoreWilliam Leiss is a Fellow and Past-President (1999-2001) of the Royal Society of Canada, and an Officer in the Order of Canada. From 1999 to 2005, he held the NSERC/SSHRC Research Chair in Risk Communication and Public Policy in the Haskayne School of Business, University of Calgary.
Read MoreDr. Tee Guidotti is an international consultant in Occupational and Environmental Health. He retired in 2008 as Professor of Occupational and Environmental Medicine at The George Washington University, where he was Chair of the Department of Environmental and Occupational Health in the School of Public Health and Health Services, and Director of the Division of Occupational Medicine and Toxicology of the Department of Medicine, School of Medicine and Health Sciences.
Read MoreDr. James Gomes, PhD is an Associate Expert with Risk Sciences International and an associate professor at the Interdisciplinary School of Health Sciences, University of Ottawa. Dr. Gomes is affiliated with the Institute of Population Health, Institute of Environment, and Center for Advanced Research in Environmental Genomics. He supervises graduate students in the Population Health Program, Epidemiology Program, Cellular and Molecular Medicine and Certificate Program in Population Health Risk Assessment.
Read MoreDr. Bird is an Associate Expert at Risk Sciences International and an Affiliate Scientist at McLaughlin Centre for Human Health Risk Assessment, and has an adjunct appointment at the Ernest Mario School of Pharmacy, Rutgers University, NJ, USA.
Read MoreSince 2002, Dr. Arnold has been a consultant to the International Aluminium Institute, the International Council on Mining and Metals, Rio Tinto, Activation Analysis Inc., TDV Global, EEM, and Sun Life.
Read MoreDr. Hartnett currently works on the development of risk-based decision-making processes and tools to support public risk assessment. Current focus includes: working with the Canadian Food Inspection Agency exploring methodologies to support risk-based monitoring of contaminants in food; working with Transport Canada to develop guidelines and methodologies to support risk-based decisions related to public risks from the transportation system; working with the U.S. Food and Drug Administration on continuing expansions and improvements to the FDA-iRISK tool.
Read More